Crafting the future of personal health!
Each patient and their journeys are unique – like a fingerprint. This requires individual therapies and patient approaches. But each patient’s story has also the unique potential to teach us something new about their disease and helps us finding more effective treatments.
At Temedica, we believe that an individual treatment is the fundamental right of every patient. It is the key to improved quality of patient care. What stands in the way is that today's medical care is generally based on a "one size fits all" principle, ignoring individual journeys of patients. This is a problem that we aim to solve.
Each patient and their journeys are unique – like a fingerprint. This requires individual therapies and patient approaches. But each patient’s story has also the unique potential to teach us something new about their disease and helps us finding more effective treatments.
At Temedica, we believe that an individual treatment is the fundamental right of every patient. It is the key to improved quality of patient care. What stands in the way is that today's medical care is generally based on a "one size fits all" principle, ignoring individual journeys of patients. This is a problem that we aim to solve.
Location: Germany, Bavaria, Munich
Employees: 51-200
Total raised: $45M
Founded date: 2016
Investors 2
| Date | Name | Website |
| 01.12.2020 | MIG AG | mig.ag |
| - | WENVEST Ca... | wenvest.ca... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.11.2022 | Series B | $26.04M | - |
| 15.01.2020 | - | $18.96M | - |
Mentions in press and media 10
| Date | Title | Description |
| 21.07.2023 | Startup Showcase: Temedica, Personalizing Healthcare Through Technology | Table of Contents show 1 Patient-Centric Approach 2 Temedica’s Digital Platforms 3 Leading the Way in Real-World Data Analysis 4 Final Thoughts Patient-Centric Approach Nestled in Munich, Germany, is the digital health company with an ... |
| 30.11.2022 | German health data company Temedica scores €25M | Photo: sturti/Getty Images |
| 24.11.2022 | Temedica sammelt 25 Millionen ein – Circus sammelt Millionen ein | Im #DealMonitor für den 24. November werfen wir einen Blick auf die wichtigsten, spannendsten und interessantesten Investments und Exits des Tages in der DACH-Region. Alle Deals der Vortage gibt es im großen und übersichtlichen #DealMonitor... |
| 24.11.2022 | Temedica Raises Additional €25M in Series B Funding | Temedica, a Munich, Germany-based health insights company, raised €25M in Series B funding. The round, which brought total funding raised to date to €42m, was led by MIG Capital, as well as a Munich-based family office. The company intends ... |
| 24.11.2022 | Munich’s Temedica adds €25 million in Series B round, now at €42 million | Munich-based medtech startup Temedica has added an additional €25 million to its Series B round, now taking the total to a healthy €42 million. The extension round was led by existing investors MIG Capital as well as an undisclosed Munich-b... |
| 23.11.2022 | 25 million Euro Series B financing for Temedica | Temedica has closed an additional 25 Euro million Series B financing to expand its Real-World Evidence ecosystem, bringing its total Series B financing to 42 million euros. Temedica from Munich wants to make a significant contribution to t... |
| 23.11.2022 | Patient-centric healthcare company Temedica raises €25M | The company develops digital companions for different diseases to get patient-generared data Temedica was founded with the aim of supporting patients with personalized medicine: the company builds digital companions for patients who have di... |
| 23.11.2022 | Temedica raises another €25 million in Series B funding to expand its unique real-world insights ecosystem | - |
| 15.01.2020 | Munich healthtech Temedica raises €17 million to rapidly expand its apps and team | Temedica, the Munich-based medtech developing apps to help people with a variety of health challenges, has raised €17 million in a round led by MIG, a VC also based in Munich. Santo Venture Capital, Salvia, and existing investors G+J Digita... |
| - | Temedica | “Temedica / Temedica: Crafting the future of personal health” |